Cargando…
17β-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo
Exogenous 17β-estradiol (E2) accelerates the progression of ovarian cancer in the transgenic tgCAG-LS-TAg mouse model of the disease. We hypothesized that E2 has direct effects on ovarian cancer cells and this study was designed to determine the molecular mechanisms by which E2 accelerates ovarian t...
Autores principales: | Laviolette, Laura A, Hodgkinson, Kendra M, Minhas, Neha, Perez-Iratxeta, Carol, Vanderhyden, Barbara C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235304/ https://www.ncbi.nlm.nih.gov/pubmed/24469735 http://dx.doi.org/10.1002/ijc.28741 |
Ejemplares similares
-
GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer
por: Hodgkinson, Kendra, et al.
Publicado: (2018) -
17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression
por: Vuong, Nhung H., et al.
Publicado: (2017) -
GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance
por: Lee, Eugine, et al.
Publicado: (2019) -
New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study
por: Plaskocinska, Inga, et al.
Publicado: (2016) -
Assessment of mismatch repair deficiency in ovarian cancer
por: Crosbie, Emma J, et al.
Publicado: (2021)